Ann: June Quarterly Activity and Cashflow Report, page-57

I was pretty happy to read that they are cutting off all non-essential projects. they already have a lot in the works and the current focus should be on building revenue which is what those statements appears to be alluding too. Again disappointed with staff costs especially when compared to Zelda.

CannEpil is the key focus in my view. If we see positive news on that in the next few weeks the SP will rise. Varm is still a faint possibility but the constant delays have soured this deal. Regardless of whether Varm goes through or not I am expecting significant revenue before the end of CY.